Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas G Gross

Showing results (11-20 of 110) with videos related to

Pageof 11
Sort By:
Expert Review of Anti-Infective Therapy|June 6, 2007
Advanced therapeutic and prophylactic strategies for Epstein-Barr virus infection in immunocompromised patientsMotohiko Okano, Thomas G Gross
Blood|June 14, 2018
Management of aggressive B-cell NHLs in the AYA population: an adult vs pediatric perspectiveKieron Dunleavy, Thomas G Gross
Current Hematologic Malignancy Reports|April 29, 2010
Pediatric non-Hodgkin lymphomaThomas G Gross, Amanda M Termuhlen
Current Oncology Reports|November 10, 2007
Pediatric non-Hodgkin's lymphomaThomas G Gross, Amanda M Termuhlen
Pediatric Transplantation|February 27, 2003
Epstein-Barr virus associated disease following blood or marrow transplantThomas G Gross, Brett J Loechelt
British Journal of Haematology|July 23, 2016
Post-transplant lymphoproliferative disorder: a heterogeneous conundrumDennis D Weisenburger, Thomas G Gross
Journal of Pediatric Hematology/Oncology|October 12, 2005
Once in a lifetimeAmanda M Termuhlen, Thomas G Gross
Pediatric Blood & Cancer|January 31, 2018
"How I approach…"-A new series in Pediatric Blood & CancerPeter E Newburger, Thomas G Gross
Cancer Treatment and Research|September 26, 2009
Hematopoietic stem cell transplantation in children and adolescents with malignant diseaseMitchell S Cairo, Thomas G Gross
Gastroenterology|March 8, 2008
Assessing the risk of epstein-barr virus-related lymphoproliferative disorders before administration of visilizumabStephen L Guthery, Thomas G Gross
Pageof 11

Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
Expert Review of Anti-Infective Therapy|June 6, 2007
Advanced therapeutic and prophylactic strategies for Epstein-Barr virus infection in immunocompromised patientsMotohiko Okano, Thomas G Gross
Blood|June 14, 2018
Management of aggressive B-cell NHLs in the AYA population: an adult vs pediatric perspectiveKieron Dunleavy, Thomas G Gross
Current Hematologic Malignancy Reports|April 29, 2010
Pediatric non-Hodgkin lymphomaThomas G Gross, Amanda M Termuhlen
Current Oncology Reports|November 10, 2007
Pediatric non-Hodgkin's lymphomaThomas G Gross, Amanda M Termuhlen
Pediatric Transplantation|February 27, 2003
Epstein-Barr virus associated disease following blood or marrow transplantThomas G Gross, Brett J Loechelt
British Journal of Haematology|July 23, 2016
Post-transplant lymphoproliferative disorder: a heterogeneous conundrumDennis D Weisenburger, Thomas G Gross
Journal of Pediatric Hematology/Oncology|October 12, 2005
Once in a lifetimeAmanda M Termuhlen, Thomas G Gross
Pediatric Blood & Cancer|January 31, 2018
"How I approach…"-A new series in Pediatric Blood & CancerPeter E Newburger, Thomas G Gross
Cancer Treatment and Research|September 26, 2009
Hematopoietic stem cell transplantation in children and adolescents with malignant diseaseMitchell S Cairo, Thomas G Gross
Gastroenterology|March 8, 2008
Assessing the risk of epstein-barr virus-related lymphoproliferative disorders before administration of visilizumabStephen L Guthery, Thomas G Gross
Pageof 11